Thomas Patrick Kelly's Net Worth

$7.17 Million

Estimate Recalculated Apr 24, 2024 03:33PM EST

Who is Thomas Patrick Kelly?

Thomas Patrick Kelly has an estimated net worth of $7.17 Million. This is based on reported shares across multiple companies, which include Deciphera Pharmaceuticals, Inc., and CRITICAL THERAPEUTICS INC.

SEC CIK

Thomas Patrick Kelly's CIK is 0001410514

Past Insider Trading and Trends

2019 was Thomas Patrick Kelly's most active year for acquiring shares with 12 total transactions. Thomas Patrick Kelly's most active month to acquire stocks was the month of January. 2019 was Thomas Patrick Kelly's most active year for disposing of shares, totalling 25 transactions. Thomas Patrick Kelly's most active month to dispose stocks was the month of December. 2019 saw Thomas Patrick Kelly paying a total of $170,100.00 for 165,000 shares, this is the most they've acquired in one year. In 2019 Thomas Patrick Kelly cashed out on 180,000 shares for a total of $4,310,767.86, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Deciphera Pharmaceuticals, Inc. (DCPH) Snapshot price: $13.99

Chief Financial Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+21.59%
14.27K
$15.62
-$47,009.28
80.35K
Feb 15 - Feb 16
Form 4
-3.55%
-2.44K
$14.47
-$35,233.96
66.08K
Jan 16
Form 4
+8.64%
5.45K
$15.37
-$42,904.94
68.52K
Dec 12 - Dec 13
Form 4
+10.37%
5.93K
$12.02
-$27,832.76
63.07K
Oct 28 - Oct 30
Form 4
-2.81%
-1.66K
$14.40
-$23,834.98
57.14K
Jun 16
Form 4
+34.61%
15.12K
$15.10
-$20,685.63
58.8K
Feb 15 - Feb 16
Form 4
-5.21%
-2.40K
$21.24
-$51,042.84
43.68K
Jan 17
Form 4
-3.70%
-1.77K
$10.75
-$19,006.00
46.08K
Jun 16
Form 4
-2.78%
-1.37K
$9.05
-$12,380.40
47.85K
Feb 16
Form 4
+71.39%
20.5K
—
—
49.22K
Jan 18
Form 4
+63.01%
11.1K
—
—
28.72K
Dec 15
Form 4
+150.23%
10.58K
$48.87
-$25,607.88
17.62K
Feb 16
Form 4
—
0
$25.95
-$144,366.30
7.04K
Scheduled
Sep 14
Form 4
—
0
$24.06
-$399,045.32
7.04K
Scheduled
Sep 8 - Sep 10
Form 4
—
0
$28.54
-$639,560.22
7.04K
Scheduled
May 11
Form 4
∞
7.04K
—
—
7.04K
Feb 18
Form 4
—
0
$29.77
-$669,061.26
0
Scheduled
Jan 2 - Jan 3
Form 4
—
0
$35.05
-$2,652,768.00
0
Dec 23
Form 4
—
0
$20.95
-$142,922.25
0
Scheduled
Oct 28
Form 4
—
0
$18.50
-$372,177.46
19.41K
Scheduled
Sep 11
Form 4
—
0
$21.58
-$442,992.99
0
Scheduled
Aug 13
Form 4
—
0
$13.45
-$4,090.47
0
Scheduled
Jun 19
Form 4
—
0
$13.55
-$48,957.93
0
Scheduled
Jun 3
Form 4
—
0
$13.48
-$34,134.81
0
Scheduled
May 21 - May 22
Form 4
—
0
$12.41
-$284,008.95
0
Scheduled
May 1
Form 4
—
0
$15.95
-$42,165.00
0
Scheduled
Feb 19
Form 4
—
0
—
—
0
Jan 30
Form 4
—
0
$13.54
-$116,450.00
0
Scheduled
Jan 7
Form 4
—
0
—
—
0
Feb 16
Form 4
—
0
—
—
0
Oct 2
Form 3
—
0
—
—
0
No matching records found

CRITICAL THERAPEUTICS INC No price found

CFO & SVP Finance & Corp. Dev,

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+62.84%
35K
—
$35.00
90.7K
Feb 14
Form 4
+81.43%
25K
—
$25.00
55.7K
Nov 5
Form 4
+14.98%
4K
$2.08
$8,319.60
30.7K
Aug 22
Form 4
∞
26.7K
—
$26.70
26.7K
Aug 20
Form 3
—
0
—
—
0
No matching records found